Skip to main content
Circulars

GP Circular 021/23 - Saxenda


Documents

Summary

GP Circular 021/23 – Saxenda, published on 18 August 2023, provides updated HSE High Tech Scheme guidance on the prescribing, reimbursement, and dispensing of Saxenda® (liraglutide) for weight management, including eligibility criteria, initiation and continuation requirements, and administrative processes for specialist-led prescribing and funding approval.


This is a beta version - your feedback will help us to improve it